Similarly, Silmitasertib transiently increased SALL2 protein levels in SW480 colon cancer cells (Fig. 5F, G, Supplementary Fig. 6A) and H1299 human lung cancer cells (Supplementary Fig. 6B). Here, SALL2 is linked to malignant colon neoplasm.